ALXO
ALXO
NASDAQ · Biotechnology

Alx Oncology Holdings Inc

$2.05
-0.01 (-0.49%)
As of Feb 8, 2:11 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 18.10M 17.71M 19.64M
Net Income 3.87M 3.06M 4.04M
EPS
Profit Margin 21.4% 17.3% 20.6%
Rev Growth +0.2% -1.6% +10.4%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 25.58M 32.72M 30.91M
Total Equity 53.35M 49.96M 47.43M
D/E Ratio 0.48 0.65 0.65
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 5.83M 6.29M 6.55M
Free Cash Flow 3.85M 4.93M 3.44M